Adverse Effects of Observational Studies When Examining Adverse Outcomes of Drugs: Case-Control Studies with Low Prevalence of Exposure

By Austin P.C.  

Drug Safety, Vol. 25, Iss. 9, 2002-01 ,pp. : 677-687

Adis International

Access to resources Recommend Favorite

Product Pipelines and Pharmaceutical Risk Management in the New Era of Strict Regulatory Scrutiny

By Sietsema William K.  

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 2, 2006-01 ,pp. : 99-106

Adis International

Access to resources Recommend Favorite

Regulatory Action Criteria for Filth and Other Extraneous Materials V. Strategy for Evaluating Hazardous and Nonhazardous Filth

By Olsen A.R.   Gecan J.S.   Ziobro G.C.   Bryce J.R.  

Regulatory Toxicology and Pharmacology, Vol. 33, Iss. 3, 2001-06 ,pp. : 363-392

Academic Press

Access to resources Recommend Favorite

Adolescence to Young Adulthood: When Socioeconomic Disparities in Substance Use Emerge

By Widome Rachel   Wall Melanie M.   Laska Melissa N.   Eisenberg Marla E.   Neumark-Sztainer Dianne  

Substance Use & Misuse, Vol. 48, Iss. 14, 2013-12 ,pp. : 1522-1529

Informa Healthcare

Access to resources Recommend Favorite

Consider adverse effects and pharmacological interactions when treating depression in HIV-positive patients

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 6, 2006-06 ,pp. : 9-11

Adis International

Access to resources Recommend Favorite